When too much ATP is a bad thing: A pivotal role for P2X7 receptors in motor neuron degeneration

Journal of Neurochemistry

Volumn 126, Issue 3, 2013, Pages 301-304

  Browne, Susan E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2X7 RECEPTOR BLOCKING AGENT; PURINERGIC P2Y2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ASTROCYTE; CALCIUM TRANSPORT; CENTRAL NERVOUS SYSTEM DISEASE; CROHN DISEASE; GLIA CELL; HUMAN; HUNTINGTON CHOREA; INFLAMMATORY DISEASE; MICROGLIA; MOTONEURON; MUSCLE ATROPHY; NERVE CELL DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROTRANSMITTER RELEASE; NONHUMAN; OLIGODENDROGLIA; PAIN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; RHEUMATOID ARTHRITIS; SPINAL CORD MOTONEURON;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; MOTOR NEURONS; PEROXYNITROUS ACID; RECEPTORS, PURINERGIC P2X7; SIGNAL TRANSDUCTION;

EID: 84880573183     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12321     Document Type: Review

References (13)

1. Atkinson L., Batten T. F., Moores T. S., Varoqui H., Erickson J. D., and, Deuchars J., (2004) Differential co-localisation of the P2X7 receptor subunit with vesicular glutamate transporters VGLUT1 and VGLUT2 in rat CNS. Neuroscience 123, 761-768.
2. Cervetto C., Alloisio S., Frattaroli D., Mazzotta M. C., Milanese M., Gavazzo P., Passalacqua M., Nobile M., Maura G., and, Marcoli M., (2013) The P2X7 receptor as a route for non-exocytotic glutamate release: dependence on the carboxyl tail. J. Neurochem. 124, 821-831.
3. Diaz-Hernandez J. I., Gomez-Villafuertes R., Leõn-Otegui M., et al,. (2012) In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases. Neurobiol. Aging 33, 1816-1828.
4. Díaz-Hernández M., Díez-Zaera M., Sánchez-Nogueiro J., Gõmez-Villafuertes R., Canals J. M., Alberch J., Miras-Portugal M. T., and, Lucas J. J., (2009) Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration. FASEB J. 23, 1893-1906.
5. Gandelman M., Peluffo H., Beckman J. S., Cassina P., and, Barbeito L., (2010) Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis. J. Neuroinflammation 7, 33-42.
6. Gandelman M., Levy M., Cassina P., Barbeito L., and, Beckman J. S., (2013) P2X7 ATP receptor-induced death of motor neurons by a peroxynitrite/FAS-dependent pathway. J. Neurochem. doi: 10.1111/jnc.12286.
7. Kang S. H., Li Y., Fukaya M., Lorenzini I., Cleveland D. W., Ostrow L. W., Rothstein J. W., and, Bergles D. E., (2013) Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 16, 571-579.
8. Moores T. S., Hasdemir B., Vega-Riveroll L., Deuchars J., and, Parson S. H., (2005) Properties of presynaptic P2X7-like receptors at the neuromuscular junction. Brain Res. 1034, 40-50.
9. 7 receptor enhances amyloid-β phagocytosis by microglia. Biochem. Biophys. Res. Commun. 434, 363-369.
10. North R. A., and, Jarvis M. F., (2013) P2X Receptors as Drug Targets. Mol. Pharmacol. 83, 759-769.
11. Vargas M. R., and, Johnson J. A., (2010) Astrogliosis in amyotrophic lateral sclerosis: Role and therapeutic potential of astrocytes. Neurotherapeutics 7, 471-481.
12. Volonté C., Apolloni S., Skaper S. D., and, Burnstock G., (2012) P2X7 receptors: channels, pores and more. CNS Neurol. Disord. Drug Targets 11, 705-721.
13. Weisman G. A., Camden J. M., Peterson T. S., Ajit D., Woods L. T., and, Erb L., (2012) P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y receptor interactions in neuroinflammation. Mol. Neurobiol. 46, 96-113.